-58.1%
CLSK vs GSK
+14.9%
-73.0%
-63.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -16.6% | +5.0% | -21.6% | -13.7% |
| 7D | -20.7% | +4.9% | -25.7% | -17.9% |
| 30D | -45.5% | +9.9% | -55.4% | -42.4% |
| 3M | -52.0% | +0.2% | -52.2% | -50.8% |
| 6M | -47.0% | +2.3% | -49.3% | -45.5% |
| YTD | -32.8% | +7.1% | -39.9% | -26.7% |
| 1Y | -58.1% | +13.1% | -71.2% | -54.9% |
| All | -58.1% | +14.9% | -73.0% | -54.9% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling